top of page
Semax 10mg
Semax 10mg

Semax 10mg

$50.00Price
Quantity

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) fragment 4-10, extensively studied for its nootropic, neuroprotective, and neurorestorative properties. Originally developed in Russia for stroke recovery, this brain-targeted peptide rapidly increases BDNF levels and modulates dopaminergic and serotonergic systems to enhance cognitive function, memory, and focus. It crosses the blood-brain barrier through direct transport via the olfactory epithelium and trigeminal nerves, allowing rapid CNS penetration.


MECHANISM OF ACTION

Semax operates through multiple pathways. It increases brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) levels, supporting neuroplasticity and neural connectivity. It modulates dopaminergic and serotonergic systems to enhance mood and motivation. The nasal route bypasses the blood-brain barrier entirely through direct transport via olfactory epithelium and trigeminal nerves, providing rapid and direct CNS access. Injectable routes provide systemic circulation and longer duration of action, though less direct brain penetration than nasal administration.

POTENTIAL BENEFITS

  • Rapid cognitive enhancement and improved focus

  • Enhanced memory consolidation and learning capacity

  • Improved attention span and mental stamina

  • Neuroprotection and neuroplasticity support

  • Stress resilience and mood stabilization

  • Brain trauma and stroke recovery support

  • Enhanced neural connectivity and cognitive flexibility

  • Sustained cognitive improvements with consistent use

WHY IT'S BEING RESEARCHED

Semax is being studied because it represents a direct, non-invasive route to enhance brain function through BDNF upregulation and neurotransmitter modulation. Clinical research shows it accelerates recovery from stroke and brain injury, improves cognitive performance in healthy adults, and enhances default mode network activity on fMRI.

INTERESTING FACTS

  • Originally developed in Russia specifically for stroke recovery

  • Increases BDNF levels rapidly — effects visible within days

  • Stroke recovery trial (2018) showed increased BDNF correlated with accelerated restoration of brain function, especially movement-related recovery

  • fMRI studies show increased default mode network activity, indicating enhanced neural connectivity

  • Injectable route provides longer duration of action and more sustained effects

  • Typical cycle: 2-4 weeks on, 1-2 weeks off to maintain sensitivity

  • Well-researched with extensive clinical data from Russian medical literature

STACKING

Common research combinations include:

  • Bromantane for synergistic cognitive and motivational enhancement — Semax upregulates BDNF/NGF while Bromantane enhances dopamine synthesis, creating complementary nootropic effects

  • Omberacetam (Noopept) for enhanced cognitive support through different mechanisms — Semax via ACTH pathways, Omberacetam via glutamatergic/cholinergic modulation

  • Selank for complementary anxiolytic effects while Semax provides cognitive enhancement

  • BPC-157 or TB-500 for comprehensive neuroprotection and brain health support

  • Cyclic Glycine


RESEARCH PURPOSES ONLY

NOT AVAILABLE FOR HUMAN CONSUMPTION

    bottom of page